Consistent with previous reports, serum spike-specific IgG titers were detected in all COVID-19 convalescent serum samples and contained functional antibodies that demonstrated live virus neutralizing activity or the capacity to block RBD-ACE2 interaction. The gene discussed is ACE2; the disease is COVID-19.